Ppard −/− mice to autoimmune kidney disease, a phenotype resembling the human disease systemic lupus erythematosus. Thus, PPAR- has a pivotal role in orchestrating the timely disposal of apoptotic cells by macrophages, ensuring that tolerance to self is maintained.
a r t i c l e s In vertebrates, resident and recruited macrophages are the professional phagocytes that rapidly clear apoptotic cells 1 . This functions to protect neighboring cells from the noxious contents of dying cells and prevents activation of the immune system by liberated cellular contents 1, 2 . Indeed, defects in apoptotic cell clearance make mice and humans susceptible to the autoimmune disease systemic lupus erythematosus [3] [4] [5] [6] . Despite the importance of apoptotic cell disposal, how macrophages transcriptionally coordinate this process remains poorly understood.
Two distinct groups of proteins facilitate the recognition and uptake of apoptotic cells by macrophages. First, factors secreted by macrophages, termed opsonins, serve as a bridge to link unique chemical moieties exposed on apoptotic cells to macrophage cell surface receptors [3] [4] [5] [6] . C1q, protein S, growth arrest-specific-6, thrombospondin-1 and milk fat globule-epidermal growth factor-8 (Mfge-8) are examples of opsonins that enhance the recognition and phagocytosis of apoptotic cells by macrophages 4, 5 . Cell surface receptors that bind opsonins comprise the second category of proteins involved in the uptake of dying cells. Members of this diverse group include the macrophage scavenger receptors, integrin and complement receptors, tyrosine kinase Mer, calreticulin and immunoglobulin and mucin domain-containing protein . In support of their pivotal role in apoptotic cell clearance, mice deficient in opsonins such as C1qa or Mfge8 or in the engulfment receptor c-mer protooncogene tyrosine kinase Mertk show heightened susceptibility to autoimmune disease on certain genetic backgrounds [8] [9] [10] [11] .
Engulfment of apoptotic cells brings large amounts of cellular lipids, including oxidized fatty acids and oxysterols, into the macrophage. We postulated that PPARs, the genetic sensors of native and oxidized fatty acids 12, 13 , are ideally suited to sense this lipid influx. Because we and others have previously shown that PPARs regulate the macrophage program of alternative activation [14] [15] [16] , it raised the question of whether these lipid sensors also orchestrate tolerogenic responses in macrophages.
RESULTS

PPAR- orchestrates timely disposal of apoptotic cells
To investigate the role of PPARs in apoptotic cell clearance, we profiled the expression of all three mouse PPARs (α, δ and γ) in primary bone marrow-derived macrophages (BMDMs) after apoptotic cell feeding (Supplementary Fig. 1a ). PPAR-δ messenger RNA, but not PPAR-γ mRNA, was induced ~200% after apoptotic cell feeding ( Fig. 1a) , whereas PPAR-α mRNA was undetectable in macrophages (data not shown). Immunoblotting confirmed that ingestion of apoptotic cells led to a ~190% increase in PPAR-δ protein abundance ( Fig. 1b) . To exclude the contribution of apoptotic cell-derived PPARδ to the signals detected in macrophages, we analyzed the expression of PPAR-δ protein in thymocytes. Intracellular staining failed to detect substantial amounts of PPAR-δ protein in thymocytes ( Fig. 1c) . In contrast, expression of PPAR-δ protein was specifically increased in macrophages fed apoptotic thymocytes ( Fig. 1c) . Moreover, we failed to detect expression of lymphocyte-specific proteins, such as the Src a r t i c l e s kinase Lck or Cd3, in macrophages fed apoptotic thymocytes ( Supplementary Fig. 1b,d) , whereas Lck and Cd3 proteins were readily detectable in thymocytes ( Supplementary  Fig. 1b,c) . Lastly, phagocytosis of latex beads, necrotic cells or opsonized sheep red blood cells (sRBCs), which are taken up via distinct pathways 6, 17 , did not induce a marked increase in PPAR-δ mRNA ( Supplementary Fig. 1e ) or protein ( Supplementary  Fig. 1f,g) . Altogether, these data demonstrate that phagocytosis of apoptotic cells induces expression of PPAR-δ in macrophages, suggesting its potential involvement in coordinating the macrophage's transcriptional response to apoptotic cells.
To test this postulate, we fed BMDMs from wild-type and Ppard −/− mice apoptotic thymocytes and quantified phagocytosis. Because doublet discrimination can distinguish between engulfed and bound cells, we monitored engulfment of fluorescence-labeled apoptotic cells by flow cytometry 18 . Strikingly, compared to wild-type macrophages, in Ppard −/− macrophages phagocytosis of apoptotic cells was lower by ~75% and ~60% at 30 and 60 min, respectively ( Fig. 1d ). We obtained similar results when we quantified phagocytosis by microscopy ( Supplementary Fig. 2a ). Furthermore, on an individual cell basis, Ppard −/− macrophages were less efficient at taking up apoptotic thymocytes, as evidenced by the lower percentage of cells containing more than two thymocytes ( Supplementary Fig. 2b,c) . This observed phagocytic defect was specific for apoptotic cells, because phagocytosis of opsonized apoptotic thymocytes, opsonized sRBCs or necrotic thymocytes was unaffected in Ppard −/− macrophages ( Supplementary Fig. 2d-f ). This impairment in phagocytosis was also independent of PPAR-δ's known role in energy metabolism ( Supplementary Fig. 2g ) 19, 20 .
We undertook two independent approaches to investigate apoptotic cell clearance in vivo. First, we injected wild-type and Ppard −/− mice with fluorescence-labeled apoptotic thymocytes and monitored splenic clearance 9 . Although we found similar numbers of apoptotic thymocytes in spleens 20 min after injection ( Fig. 1e) , the relative clearance of apoptotic cells was delayed in Ppard −/− mice. At 4 h, approximately twofold more fluorescent cells were present in the spleens of Ppard −/− mice (1.38% versus 2.7%) ( Fig. 1e) . Similarly, resident peritoneal macrophages of Ppard −/− mice showed a lower capacity for clearance of fluorescence-labeled apoptotic cells ( Fig. 1f) . Six hours after intraperitoneal injection of apoptotic thymocytes, the number of free thymocytes recovered from the peritoneum of Ppard −/− mice was approximately fivefold higher than in wildtype mice (0.43% versus 2.02%) ( Fig. 1f) . These findings demonstrate that PPAR-δ promotes timely disposal of apoptotic cells in various macrophage populations.
PPAR- regulates opsonin gene expression in macrophages
To identify the molecular targets by which PPAR-δ regulates apoptotic cell clearance, we monitored expression of opsonins and their cognate receptors by microarray analysis. Clustering analyses revealed that a number of genes encoding opsonins, including C1qa, C1qb, C1qc, Gas6 (encoding growth arrest specific-6), Mfge8 and Thbs1 (encoding thrombospondin-1), were downregulated in Ppard −/− macrophages ( Fig. 2a) . In contrast, the expression of macrophage receptors that recognize these 'eat-me' signals was largely unchanged, with the notable exception of Mertk ( Fig. 2a) . Quantitative PCR (qRT-PCR) analysis confirmed that expression of C1qa, C1qb, Mfge8, Mertk and Thbs1 was 60-70% lower in Ppard −/− BMDMs (Fig. 2b) . In agreement, immunoblot analysis revealed a ~300% decrease in C1qb protein abundance in Ppard −/− macrophages ( Fig. 2c) .
To determine whether activation of PPAR-δ can enhance opsonin gene expression in macrophages, we treated wild-type BMDMs with the PPAR-δ agonist GW0742 (ref. 21) , and we monitored opsonin gene expression by qRT-PCR. Indeed, PPAR-δ activation induced C1qa, C1qb, Mfge8 and Thbs1 by ~200-300% ( Fig. 2d ) in a PPARδ-dependent manner ( Supplementary Fig. 3b ). Finally, because mutations in C1q are responsible for the monogenic form of systemic lupus erythematosus in humans 22 , we investigated whether C1qb is a direct transcriptional target of PPAR-δ. In silico analysis revealed a consensus PPAR-δ binding site in the C1qb gene located at ~−1.6 kilobases. Deletion analysis of the mouse promoter affirmed that PPAR-δ-RXR heterodimers directly regulate C1qb gene expression ( Fig. 2e and Supplementary Fig. 3a) .
We next tested whether pharmacologic activation of PPAR-δ enhances phagocytosis of apoptotic cells. Notably, treatment of wild-type mice with GW0742 enhanced the ability of CD11b + splenic macrophages to phagocytose labeled apoptotic thymocytes by ~200% ( Fig. 3a) . To extend these findings to human cells, we treated primary human monocyte-derived macrophages with GW0742. Both opsonin gene expression ( Fig. 3b ) and apoptotic cell uptake ( Fig. 3c) were enhanced in human macrophages stimulated with GW0742, indicating conservation of this pathway between mice and humans.
Kupffer cells are the primary source of the opsonins that circulate in the serum [23] [24] [25] , prompting us to investigate whether opsonin expression was lower in livers of Ppard −/− mice. Indeed, we found substantially lower expression of C1qa, C1qb, Thbs1 and Mfge8 Fig. 3c ). Conversely, treatment of wild-type mice with GW0742 increased hepatic opsonin gene expression by ~50-90% ( Supplementary  Fig. 3d ). Congruent with these observations, circulating levels of C1qb ( Fig. 3d ) and, to a lesser extent, Mfge8 (Supplementary Fig. 3e ) were lower in Ppard −/− mice. To determine whether the reduction in opsonin abundance contributes to the phagocytic defect of Ppard −/− macrophages, we performed a series of experiments using sera from wild-type and Ppard −/− mice. The observed phagocytic defect in Ppard −/− macrophages was largely rescued by sera from wild-type mice (Fig. 3e) , whereas incubation of wild-type macrophages with Ppard −/− sera reduced their phagocytic capacity by ~35% ( Fig. 3e) . Similarly, addition of purified human C1q protein to Ppard −/− macrophages restored their phagocytic activity to ~90% of wild-type macrophages (Fig. 3f) . We thus conclude that PPAR-δ orchestrates the prompt disposal of dying cells in mouse and human macrophages by inducing expression of opsonins.
PPAR-δ is a transcriptional sensor of apoptotic cells
Apoptotic cells contain large amounts of native and oxidized fatty acids, leading us to ask whether they might activate PPAR-δ to enhance their own clearance. To explore this possibility, we performed transient transfection assays with the PPAR reporter gene (AOx-PPRE 3 -Luc). Treatment of transfected cells with apoptotic thymocytes increased luciferase reporter gene activity only in the presence of PPAR-δ ( Supplementary Fig. 4a ). Moreover, reporter gene assays with GAL4-PPAR-δ chimeric constructs confirmed that the ligand-binding domain of PPAR-δ is sufficient to transduce the transcriptional effects of apoptotic thymocytes (Supplementary Fig. 4b ).
Congruent with these data, apoptotic cell feeding induced expression of opsonins (C1qb, Mfge8 and Thbs1), Mertk, Tgfb1 (encoding transforming growth factor-β1 (TGF-β1)) and the PPAR-δ target gene Plin2 (encoding perilipin-2) in thioglycollate-elicited wild-type 
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Ppard a r t i c l e s macrophages (Fig. 4a) , whereas the induction of all of these genes was diminished or absent in Ppard −/− macrophages (Fig. 4a) . Moreover, challenge of wild-type but not Ppard −/− macrophages with apoptotic cells led to a ~650% increase in C1q protein abundance (C1qa, C1qb and C1qc) ( Fig. 4b) , leading us to postulate that apoptotic cells might enhance their own clearance via activation of PPAR-δ. To test this idea, we did a double-feeding experiment with BMDMs. Notably, priming of wild-type macrophages by apoptotic cells increased their phagocytic capacity by ~60%, whereas there was no significant difference in the phagocytic capacity of macrophages lacking PPAR-δ ( Fig. 4c) . Finally, this transcriptional activation of PPAR-δ by apoptotic cells was specific, because necrotic cells and opsonized sRBCs failed to activate PPAR-δ ( Supplementary Fig. 4c,d) .
Previous work has established that phagocytosis of apoptotic cells suppresses autoimmune responses by releasing immunosuppressive cytokines (interleukin-10 (IL-10) and TGF-β) and inhibiting production of proinflammatory cytokines (IL-12 and tumor necrosis factor-α (TNF-α)) 3, 26, 27 . Because PPAR-δ functions as a sensor of apoptotic cells, we asked whether it might mediate this molecular switch in cytokine secretion. For these experiments, we stimulated thioglycollate-elicited wild-type and Ppard −/− macrophages with lipopolysaccharide (LPS) in the presence or absence of apoptotic cells, and cytokine secretion was monitored by ELISA. As expected, apoptotic cell feeding increased secretion of the anti-inflammatory cytokine IL-10 ( Fig. 4d) while suppressing the release of the proinflammatory cytokines IL-12 and TNF-α in wild-type macrophages (Fig. 4e,f) . Of note, this switch in cytokine secretion pattern was absent in Ppard −/− macrophages ( Fig. 4d-f ), suggesting that immunosuppressive effects of apoptotic cells require an intact PPAR-δ signaling pathway in macrophages.
Ppard −/− mice develop autoimmune disease
Defective clearance of apoptotic cells triggers immune response to self antigens, manifesting as lupus-like autoimmunity in mice 8, 9, 11, 28 . Because we observed lower expression of opsonins and impaired clearance of apoptotic cells in Ppard −/− mice, we evaluated the onset of autoimmune disease in these mice. Notably, sera of Ppard −/− female mice (n = 9) had ~200-600% higher levels of autoantibodies, including those directed against nuclear antigens (antinuclear antibody, ANA; double-stranded DNA, dsDNA; single-stranded DNA, ssDNA) and cardiolipin, than age-matched wild-type controls (n = 7; Fig. 5a-d) . Furthermore, these changes in autoantibody titers were comparable to those found in wild-type BALB/c mice treated with pristane, an established model for inducing lupus-like autoimmunity 29, 30 . A hallmark of systemic lupus erythematosus is the deposition of autoantibodies as immune complexes in the kidney, leading to inflammation and destruction of the glomeruli 31 . Indeed, immunofluorescence staining revealed that the glomeruli of all Ppard −/− female mice (n = 7) had a ribbon-like pattern of IgG deposition, whereas the glomeruli of wild-type female mice were largely spared (Fig. 5e) . Accordingly, increased urinary protein excretion, a sign of kidney dysfunction, was present in Ppard −/− female mice (Fig. 5f) . Moreover, perivascular inflammation, a common histological finding in autoimmune kidney disease 32, 33 , was increased by ~600% in the kidneys of Ppard −/− female mice (Supplementary Fig. 5a,b) . We obtained similar results in an independent cohort of wild-type and Ppard −/− female mice (n = 8 per genotype; Supplementary Fig. 6) .
To determine whether the lupus-like autoimmunity in Ppard −/− female mice results from changes in lymphocyte subsets, we analyzed the spleens of 13-week-old female mice before they had any evidence of autoimmune disease. Notably, total numbers of B cells and CD4 + and CD8 + T cells were not different between wild-type and Ppard −/− female mice (Supplementary Figs. 7a, 8a and 9b) . The numbers of regulatory, memory, naive and activated T cells and activated B cells were also similar amongst the genotypes (Supplementary Fig. 7a,  8a,b and 9a) . Furthermore, spleen weights and splenic lymphocyte composition were similar in 14-month-old wild-type and Ppard −/− female mice (Supplementary Fig. 7b,c) , suggesting that the autoimmunity in these mice is not due to aberrant proliferation or activation of lymphocytes.
To further explore this idea, we investigated whether mice deficient in Ppard specifically in their macrophages (Mac-Ppard −/− mice) showed similar defects in clearance of apoptotic cells. Genetic deletion of PPAR-δ in macrophages was sufficient to lower opsonin gene expression by 35-75% ( Fig. 6a) and impair clearance of 5-chloromethylfluorescein diacetate (CMFDA)-labeled apoptotic thymocytes by ~350% in the spleen (Fig. 6b) . Remarkably, this delay in clearance of apoptotic cells resulted in higher levels of autoantibodies a r t i c l e s specific for ssDNA and cardiolipin in 3-to 6-month-old female Mac-Ppard −/− mice ( Fig. 6c-e ; n = 8 per genotype). Because Mac-Ppard −/− mice were generated on the C57BL/6J background 15 , a strain known to be very resistant to spontaneous lupus-like autoimmune disease 34, 35 , we injected apoptotic thymocytes in a separate cohort of mice to potentiate autoimmunity 36, 37 . Injection of syngeneic apoptotic cells increased titers dsDNA-specific and ssDNA-specific antibodies by ~200% ( Fig. 6f,g) in Mac-Ppard −/− mice, resulting in increased perivascular inflammation and immune complex deposition in the kidney (Fig. 6h,i ; n = 6 or 7 per genotype). Together, these data show that deletion of PPAR-δ in macrophages is sufficient to delay clearance of apoptotic cells, thereby providing the antigenic stimulus for breakdown of tolerance. Systemic lupus erythematosus is a polygenic disease involving hits in multiple pathways, including B cell signaling and activation, apoptotic cell clearance and Toll-like receptor signaling 38, 39 . As global or macrophage-specific deficiency of PPAR-δ primarily affects pathways of apoptotic cell clearance, we next investigated whether additional hits could potentiate autoimmunity in mice deficient in PPAR-δ. For these experiments, we gave cohorts of wild-type a r t i c l e s (n = 6-8) and Ppard −/− (n = 8-10) female mice a single injection of pristane, which induces lupus-like autoimmune disease by activating B cells 30 . As expected, wild-type female mice treated with pristane had higher levels of antibodies directed against nuclear and membranous antigens, including antibody to cardiolipin, antinuclear antibody, antibody to dsDNA and antibody to ssDNA, than their saline-injected littermates (Supplementary Fig. 10a-d) . Notably, the concentrations of these antibodies in sera of pristane-treated Ppard −/− female mice were ~200-400% higher than in pristane-treated wild-type controls (Supplementary Fig. 10a-d) , and the penetrance of pristane-induced autoimmunity was increased from 28% to 77% in pristane-treated Ppard −/− female mice (Supplementary Fig. 10e ). In agreement with these results, massive deposits of complement-containing immune complexes were only seen in the glomeruli of pristane-injected Ppard −/− female mice (Supplementary Fig. 10f ). Furthermore, histological analysis revealed that whereas glomeruli of wild-type female mice had mild to moderate mesangial hypercellularity (precursor lesions), severe endocapillary proliferative glomerulonephritis with necrosis and crescent formation (end-stage lesions) were the dominant pathologies present in the glomeruli of Ppard −/− female mice ( Supplementary Fig. 10g,h) . Together, these data show that genetic deficiency of PPAR-δ delays clearance of apoptotic cells and increases autoantibody production, leading to immune complex-mediated glomerulonephritis, features reminiscent of the human disease systemic lupus erythematosus.
DISCUSSION
During the past decade, numerous molecules responsible for recognition and uptake of apoptotic cells have been identified. Careful dissection of these pathways has revealed that prompt clearance of apoptotic cells by macrophages is essential for prevention of autoimmune disease. Notably, apoptotic cells are rapidly cleared by macrophages even during times of massive apoptosis 40, 41 , implying that phagocytic programs are dynamic, allowing macrophages to adapt to their changing microenvironment. However, the transcription factors that coordinate expression of phagocytic genes remain unknown. Our results show that the nuclear receptor PPAR-δ functions as a sensor of dying cells to orchestrate the phagocytic response when macrophages are confronted with apoptotic cells. After engulfment, apoptotic bodies are rapidly broken down into their molecular constituents. This results in a marked increase in the cellular pools of oxidized fatty acids and sterols, the normal components of the cellular membranes of apoptotic cells. Since PPARs and liver X receptors are sensors of modified fatty acids and sterols, respectively 12,42 , we and others have postulated that they might coordinate the transcriptional response of macrophages during apoptotic cell clearance 6, 43 . Indeed, the evidence presented here provides strong support for a pivotal role of nuclear receptor signaling in the phagocytic response. Specifically, we demonstrate that apoptotic cell feeding potently induces and activates PPAR-δ, which then enhances the expression of opsonins, molecules that bridge apoptotic bodies to cell surface receptors on phagocytes. In addition, by sensing apoptotic cells, PPAR-δ functions as a molecular switch that discriminates between the proinflammatory and immunosuppressive actions of macrophages. Consequently, global or macrophage-specific deletion of PPAR-δ delays clearance of apoptotic cells, leading to increased production of autoantibodies and progressive lupus-like autoimmune disease.
The requirement for PPAR-δ in regulation of the expression of opsonin genes such as C1qb provides a direct link between this transcription factor, phagocytosis of apoptotic cells and development of autoimmune disease in mice and humans. Notably, loss of PPAR-δ signaling in the macrophage lowers expression of key opsonins, including C1qa, C1qb, Mfge8 and Thbs1. Because genetic deletion of C1qb and Mfge8 delays clearance of apoptotic debris by macrophages 11, 28 , the concomitant reduction of these opsonins provides a molecular explanation for the lower uptake of apoptotic cells by macrophages lacking PPAR-δ. Thus, we propose that the persistence of apoptotic debris and increased macrophage inflammatory responses to them in global or macrophage-specific Ppard −/− mice provides the antigenic stimulus that potentiates autoimmunity in these mice. Increased titers of autoantibodies and progressive renal pathology collectively suggest that PPAR-δ-deficient mice are a good model system for studying human systemic lupus erythematosus.
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